6Vardi M, Zittan E, Bitterman H. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism [J/OL]. Cochrane Database Syst Rev,2009,0ct 7,(4):CD006771. 被引量：1
7Kearon C, Ginsberg JS, Julian JA.Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism [ J ]. JAMA,2006,296(8):935-942. 被引量：1
8Daskalopoulos ME, Daskalopoulou SS, Tzortzis E,et al.Long-term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial [J]. Eur J Vase Endovase Surg, 2005, 29(6):638-650. 被引量：1
9Akl EA,Rohilla S,Barba M.Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer[J/OL]. Cochrane Database Syst Rev, 2008, Jan 23,(1):CD006649. 被引量：1
2Cohen AT, Agnelli G, Anderson FA, et al.Venous thromboembo- lism (~TE) in Europe. The number of YTE events and associated morbidity and mortality [J].Thromb Haemost, 2007, 98(4): 756-764. 被引量：1
3Kahn SR, Shrier I, Julian JA, et al.Detemfinants and time course of the postthrombotic syndrome after acute deep venous throm- bosis [J ] .Ann Intern Med,2008,149(10): 698-707. 被引量：1
4Kearon C, Akl EA, Cemerota AJ, et aLAntithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed : American College of Chest Physicians Evi- dence-Based Clinical Practice Guidelines [J].Chest,2012, 141 (suppl) : 419-494. 被引量：1
5Howard LS, Hughes RJ.NICE guideline : management of venous thromboembolic diseases and role of thrombophilia testing [J]. Thorax,2013, 68 : 391-393. 被引量：1
6Perzborn E, Roehrig S, Straub A, et al. Rivaroxaban: a new oral factor Xa inhibitor [J].Arterioscler Thromb Vasc Biol,2010, 30: 376-381. 被引量：1
7Prins MH, Lensing AW, Bauersachs R, et al.Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies [ J ].Thromb J, 2013,11 ( 1 ) : 21. 被引量：1
8Wang Y, Wang C, Chen Z, et al. Rivaroxaban for the treatment of symptomatic deep-vein thrombosis and pulmonary embolism in Chinese patients: a subgroup analysis of the EINSTEIN DVT and PE studies [ J ] .Thromb J, 2013,11 ( 1 ) : 25. 被引量：1
9Liew A, Douketis J.Initial and long-term treatment of deep ve- nous thrombosis : recent clinical trials and their impact on pa- tient management [J].Expert Opin Pharmacother,2013, 14: 385-396. 被引量：1
10Mehrzad H, Freedman J, Harvey JJ, et al.The role of interven- tional radiology in the management of deep vein thrombosis [ J ]. Postgrad Med J, 2013,89(1049): 157-164. 被引量：1
